Detalhe da pesquisa
1.
The impact of daratumumab pretreatment on multiple myeloma patients undergoing autologous transplantation.
Cancer Sci
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38757410
2.
Cytomegalovirus Reactivation during Elotuzumab Therapy in Patients with Multiple Myeloma.
Acta Haematol
; : 1-6, 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38657575
3.
Eosinophil-rich variant of nodal marginal zone lymphoma: a clinicopathological study of 11 cases.
Histopathology
; 83(3): 443-452, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37222201
4.
Changing trends in the risk factors for second primary malignancies after autologous stem cell transplantation for multiple myeloma before and after the introduction of proteasome inhibitors and immunomodulatory drugs.
Haematologica
; 108(12): 3399-3408, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37470160
5.
Adverse impact of delay of platelet recovery after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma and multiple myeloma.
Cytotherapy
; 25(11): 1212-1219, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37354150
6.
Real-world clinical outcomes in patients with multiple myeloma treated with isatuximab after daratumumab treatment.
Ann Hematol
; 102(6): 1477-1483, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37115297
7.
Real-world clinical outcomes in patients with relapsed and refractory multiple myeloma receiving VTD-PACE treatment in the era of monoclonal antibodies.
Ann Hematol
; 102(12): 3489-3497, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37668787
8.
Clinical significance of late CMV disease in adult patients who underwent allogeneic stem cell transplant.
J Infect Chemother
; 29(12): 1103-1108, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37532223
9.
[Updated treatment strategy for transplant-eligible multiple myeloma: current status and future perspectives].
Rinsho Ketsueki
; 64(9): 1066-1073, 2023.
Artigo
em Japonês
| MEDLINE | ID: mdl-37899184
10.
[A retrospective analysis of 124 patients with multiple myeloma who received up-front autologous hematopoietic cell transplantation following triplet induction therapy].
Rinsho Ketsueki
; 64(11): 1397-1403, 2023.
Artigo
em Japonês
| MEDLINE | ID: mdl-38072424
11.
[Acute myeloid leukemia with t (8;21) translocation diagnosed at 21 weeks of gestation resulting in full-term delivery without chemotherapy].
Rinsho Ketsueki
; 64(8): 731-734, 2023.
Artigo
em Japonês
| MEDLINE | ID: mdl-37673623
12.
Long-term outcomes following the addition of granulocyte colony-stimulating factor-combined high-dose cytarabine to total body irradiation and cyclophosphamide conditioning in single-unit cord blood transplantation for myeloid malignancies.
Ann Hematol
; 101(1): 177-189, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34591162
13.
Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine.
Cancer Sci
; 112(12): 5034-5045, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34644446
14.
Minimal residual disease detection in multiple myeloma: comparison between BML single-tube 10-color multiparameter flow cytometry and EuroFlow multiparameter flow cytometry.
Ann Hematol
; 100(12): 2989-2995, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34430990
15.
Outcomes and Prognostic Factors for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A KSGCT Multicenter Analysis.
Biol Blood Marrow Transplant
; 26(5): 998-1004, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31962165
16.
Hematopoietic Stem Cell Transplantation in Solid Organ Recipients with Emphasis on Transplant Complications: A Nationwide Retrospective Survey on Behalf of the Japan Society for Hematopoietic Stem Cell Transplantation Transplant Complications Working Group.
Biol Blood Marrow Transplant
; 26(1): 66-75, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31494230
17.
The efficacy and safety of modified bortezomib-lenalidomide-dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma.
Eur J Haematol
; 104(2): 110-115, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31733155
18.
[Cost-effectiveness of peripheral blood stem cell collection using plerixafor: a single-center study].
Rinsho Ketsueki
; 61(11): 1563-1569, 2020.
Artigo
em Japonês
| MEDLINE | ID: mdl-33298647
19.
Prognostic value of the second revision of the international staging system (R2-ISS) in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation.
Hematol Oncol
; 42(1): e3248, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38287531
20.
Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation.
Hematol Oncol
; 37(5): 586-594, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31674032